With the blessing of US regulator FDA, Paradigm Biopharma hopes to launch its pivotal trial of its knee osteoarthritis drug candidate.

Sentiment in the lithium space has improved this month, largely thanks to Rio Tinto’s US$6.7 billion deal to acquire Arcadium ...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes ...

Netflix shares up 11pc on strong profits. TSMC crucial for chip production, and investors should watch this stock.

Norwest Minerals (ASX:NWM) has hit volcanogenic massive sulphide style mineralisation in RC drilling at its West Arunta ...

One is a legend of the game, the other a rising star. Together Sky's Norm Seckold and Ollie Davies want to reshape the ASX ...

BlackRock's latest insights highlight key investment opportunities for Aussie investors, focusing on global stocks and ...

The "sweet spot" for ASX small cap investing is in high-quality companies with long-term competitive potential: ICE Investors ...

Tony Locantro goes psychedelic to discuss Tryptamine Therapeutics and its successes in an ASX sector which could soon be ...

Malcolm Day joins Barry FitzGerald on the Explorers Podcast to talk about acquiring new uranium ground in Tanzania.

D3 Energy’s production testing of RBD01 in ER315 will evaluate its reservoir characteristics, flow rates, pressure responses ...

Make the most of your holiday by squeezing in a cheeky extended stopover. Here's how to DIY (without involving a travel agent ...